176 related articles for article (PubMed ID: 3904801)
41. Immunohistochemical analysis of CEA in colorectal adenomas with and without early cancer.
Gloghini A; Gatteschi MB; Nicolò G
Pathologica; 1987; 79(1062):437-46. PubMed ID: 3451162
[No Abstract] [Full Text] [Related]
42. Immunohistochemical study of ras p21 expression in human gastric cancers and benign lesions.
Nakajima K; Kuzumaki N; Oda A; Kobayashi H; Katoh H; Tanabe T
Oncology; 1989; 46(4):260-5. PubMed ID: 2662090
[TBL] [Abstract][Full Text] [Related]
43. Immunolocalization of ras oncogene p21 in human liver diseases.
Radosevich JA; Gould KA; Koukoulis GK; Haines GK; Rosen ST; Lee I; Gould VE
Ultrastruct Pathol; 1993; 17(1):1-8. PubMed ID: 8381245
[TBL] [Abstract][Full Text] [Related]
44. Absolute values of ras p21 defined by direct binding liquid competition radioimmunoassays.
Horan Hand P; Vilasi V; Caruso A; Schlom J
Biochim Biophys Acta; 1987 Feb; 908(2):131-42. PubMed ID: 3814600
[TBL] [Abstract][Full Text] [Related]
45. Reversal of transformed phenotype by monoclonal antibodies against Ha-ras p21 proteins.
Kung HF; Smith MR; Bekesi E; Manne V; Stacey DW
Exp Cell Res; 1986 Feb; 162(2):363-71. PubMed ID: 3510879
[TBL] [Abstract][Full Text] [Related]
46. Detection of activated ras oncogenes in human thyroid carcinomas.
Suárez HG; Du Villard JA; Caillou B; Schlumberger M; Tubiana M; Parmentier C; Monier R
Oncogene; 1988 Apr; 2(4):403-6. PubMed ID: 3283656
[TBL] [Abstract][Full Text] [Related]
47. Localization and imaging of radiolabeled monoclonal antibodies against colorectal carcinoma in tumor-bearing nude mice.
Buchsbaum D; Lloyd R; Juni J; Wollner I; Brubaker P; Hanna D; Spicker J; Burns F; Steplewski Z; Colcher D
Cancer Res; 1988 Aug; 48(15):4324-33. PubMed ID: 3390828
[TBL] [Abstract][Full Text] [Related]
48. Glycosaminoglycans of rat colorectal adenocarcinoma.
Isemura M; Munakata H; Ototani N; Goto K; Yosizawa Z
Gan; 1982 Oct; 73(5):721-7. PubMed ID: 6819975
[TBL] [Abstract][Full Text] [Related]
49. Immunohistochemical detection of ras p21 oncoprotein in undifferentiated and well-differentiated epithelial carcinomas of the human ovary.
Kuwashima Y; Shisa H; Uehara T; Kurosumi M; Kobayashi Y; Tanuma J; Shiromizu K; Matsuzawa M; Kishi K
Anticancer Res; 1995; 15(6B):2847-50. PubMed ID: 8669877
[TBL] [Abstract][Full Text] [Related]
50. Expression of ras oncogene p21 protein in relation to regional spread of human breast carcinomas.
Czerniak B; Chen R; Tuziak T; Markiewski M; Kram A; Gorczyca W; Deitch D; Herz F; Koss LG
Cancer; 1989 May; 63(10):2008-13. PubMed ID: 2467732
[TBL] [Abstract][Full Text] [Related]
51. [Immunohistochemical study of ras p21 expression in human gastric cancers and benign lesions].
Nakajima K
Hokkaido Igaku Zasshi; 1987 Jul; 62(4):573-80. PubMed ID: 3315926
[TBL] [Abstract][Full Text] [Related]
52. Neutralizing monoclonal antibody against ras oncogene product p21 which impairs guanine nucleotide exchange.
Hattori S; Clanton DJ; Satoh T; Nakamura S; Kaziro Y; Kawakita M; Shih TY
Mol Cell Biol; 1987 May; 7(5):1999-2002. PubMed ID: 2439901
[TBL] [Abstract][Full Text] [Related]
53. Quantitation of mRNA and protein products of the Ha-ras-1 proto-oncogene.
Gambari R; Giacomini P
Breast Cancer Res Treat; 1990 Oct; 16(3):287-9, 291. PubMed ID: 2085679
[No Abstract] [Full Text] [Related]
54. [Histochemical study of the mucins in the mucosa adjacent to colo-rectal carcinomas associated with single or multiple adenomatous polyps].
Lapertosa G; Fulcheri E; Pietra A
Pathologica; 1981; 73(1025):467-71. PubMed ID: 7267163
[No Abstract] [Full Text] [Related]
55. Evidence of enhancement of the ras oncogene protein product (p21) in a spectrum of human tumors.
De Biasi F; Del Sal G; Hand PH
Int J Cancer; 1989 Mar; 43(3):431-5. PubMed ID: 2784420
[TBL] [Abstract][Full Text] [Related]
56. A critical appraisal of the immunohistochemical detection of the c-myc oncogene product in colorectal cancer.
Jones DJ; Ghosh AK; Moore M; Schofield PF
Br J Cancer; 1987 Dec; 56(6):779-83. PubMed ID: 3325094
[TBL] [Abstract][Full Text] [Related]
57. Activated Val-12 ras p21 in cell culture fluids and mouse plasma.
Hamer PJ; La Vecchio J; Ng S; DeLellis R; Wolfe H; Carney WP
Oncogene; 1991 Sep; 6(9):1609-15. PubMed ID: 1923528
[TBL] [Abstract][Full Text] [Related]
58. Expression of ras oncogene p21 in prostate cancer.
Viola MV; Fromowitz F; Oravez S; Deb S; Finkel G; Lundy J; Hand P; Thor A; Schlom J
N Engl J Med; 1986 Jan; 314(3):133-7. PubMed ID: 2417118
[TBL] [Abstract][Full Text] [Related]
59. Mutation affecting the 12th amino acid of the c-Ha-ras oncogene product occurs infrequently in human cancer.
Feinberg AP; Vogelstein B; Droller MJ; Baylin SB; Nelkin BD
Science; 1983 Jun; 220(4602):1175-7. PubMed ID: 6304875
[TBL] [Abstract][Full Text] [Related]
60. Characterization of monoclonal antibody R256, specific for activated ras p21 with arginine at 12, and analysis of breast carcinoma of v-Harvey-ras transgenic mouse.
Pullano TG; Sinn E; Carney WP
Oncogene; 1989 Aug; 4(8):1003-8. PubMed ID: 2474786
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
